• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对肿瘤≤2厘米的非小细胞肺癌患者进行肺叶下切除术的肺叶特异性分析

Lobe-Specific Analysis of Sublobar Lung Resection for NSCLC Patients with Tumors ≤ 2 cm.

作者信息

Lei Xi, Zhou Ning, Zhang Hao, Li Tong, Ren Fan, Zhang Bo, Li Xiongfei, Zu Lingling, Song Zuoqing, Xu Song

机构信息

Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China.

Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China.

出版信息

Cancers (Basel). 2022 Jul 4;14(13):3265. doi: 10.3390/cancers14133265.

DOI:10.3390/cancers14133265
PMID:35805037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9265391/
Abstract

(1) Background: Sublobar resection can be used as an alternative surgical strategy for early-stage non-small-cell lung cancer (NSCLC) patients. However, the choice between wedge resection and segmentectomy remains contentious. In this study, we investigated the optimal surgical procedure for sublobar resection in patients with NSCLC ≤ 2 cm with a lobe-specific analysis; (2) Methods: Data for patients with T1N0M0 with a diameter of ≤2 cm who had undergone sublobar resection were retrieved. Propensity score matching (PSM) was used to reduce the inherent bias, and the Kaplan-Meier method and log-rank tests were used to assess the differences in survival; (3) Results: A total of 1882 patients were identified after the PSM. Patients with NSCLC ≤ 2 cm who had undergone segmentectomy showed better survival than those who had undergone wedge resection. However, when NSCLC was ≤1 cm, there was no significant difference in OS between the two groups. This demonstrated an OS advantage of segmentectomy over wedge resection for patients with NSCLC tumors of 1-2 cm ( = 0.024). Further analysis indicated that this survival benefit was only observed in patients with right upper NSCLC of 1-2 cm, but not with NSCLC in the other four lobes; (4) Conclusions: Segmentectomy showed a greater survival benefit than wedge resection only in patients with NSCLC of 1-2 cm, particularly those with primary tumors in the right upper lobe. Therefore, we propose a lobe-specific sublobar resection strategy for early-stage NSCLC patients (tumors of 1-2 cm) who cannot tolerate lobectomy.

摘要

(1) 背景:肺叶下切除可作为早期非小细胞肺癌(NSCLC)患者的一种替代手术策略。然而,楔形切除和肺段切除之间的选择仍存在争议。在本研究中,我们通过肺叶特异性分析,探讨了直径≤2 cm的NSCLC患者肺叶下切除的最佳手术方式;(2) 方法:检索接受肺叶下切除的直径≤2 cm的T1N0M0患者的数据。采用倾向评分匹配(PSM)来减少内在偏倚,并使用Kaplan-Meier法和对数秩检验来评估生存差异;(3) 结果:PSM后共确定1882例患者。接受肺段切除的直径≤2 cm的NSCLC患者的生存率高于接受楔形切除的患者。然而,当NSCLC≤1 cm时,两组的总生存期无显著差异。这表明对于1-2 cm的NSCLC肿瘤患者,肺段切除在总生存期方面优于楔形切除(P = 0.024)。进一步分析表明,这种生存获益仅在1-2 cm的右上叶NSCLC患者中观察到,而在其他四个肺叶的NSCLC患者中未观察到;(4) 结论:仅在1-2 cm的NSCLC患者中,尤其是原发肿瘤位于右上叶的患者,肺段切除显示出比楔形切除更大的生存获益。因此,我们为不能耐受肺叶切除的早期NSCLC患者(肿瘤1-2 cm)提出一种肺叶特异性肺叶下切除策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d3/9265391/0c4f75b11586/cancers-14-03265-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d3/9265391/673d15e1c416/cancers-14-03265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d3/9265391/96921e0b4eaa/cancers-14-03265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d3/9265391/2ab5c4a2c4e7/cancers-14-03265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d3/9265391/5567029248a7/cancers-14-03265-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d3/9265391/0c4f75b11586/cancers-14-03265-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d3/9265391/673d15e1c416/cancers-14-03265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d3/9265391/96921e0b4eaa/cancers-14-03265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d3/9265391/2ab5c4a2c4e7/cancers-14-03265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d3/9265391/5567029248a7/cancers-14-03265-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d3/9265391/0c4f75b11586/cancers-14-03265-g005.jpg

相似文献

1
Lobe-Specific Analysis of Sublobar Lung Resection for NSCLC Patients with Tumors ≤ 2 cm.对肿瘤≤2厘米的非小细胞肺癌患者进行肺叶下切除术的肺叶特异性分析
Cancers (Basel). 2022 Jul 4;14(13):3265. doi: 10.3390/cancers14133265.
2
Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.cStage IA期肺鳞状细胞癌患者手术入路的选择:一项基于人群的倾向评分匹配分析。
Front Oncol. 2022 Aug 23;12:946800. doi: 10.3389/fonc.2022.946800. eCollection 2022.
3
Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer.右中叶早期非小细胞肺癌行肺叶切除术与亚肺叶切除术的生存率。
Thorac Cancer. 2018 Aug;9(8):1026-1031. doi: 10.1111/1759-7714.12782. Epub 2018 Jun 21.
4
Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.I 期非小细胞肺癌:波兰国家肺癌登记处肺叶切除术与亚肺叶切除术的长期结果。
Eur J Cardiothorac Surg. 2017 Aug 1;52(2):363-369. doi: 10.1093/ejcts/ezx092.
5
Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.≤1 厘米或>1 至 2 厘米的非小细胞肺癌患者的手术方式选择:肺叶切除术、节段切除术和楔形切除术:一项基于人群的研究。
J Clin Oncol. 2016 Sep 10;34(26):3175-82. doi: 10.1200/JCO.2015.64.6729. Epub 2016 Jul 5.
6
Is wedge resection equivalent to segmentectomy in pathological stage IA (≤2 cm) non-small cell lung cancers?楔形切除术与肺段切除术在病理ⅠA 期(≤2cm)非小细胞肺癌中的疗效相当吗?
Thorac Cancer. 2024 Jul;15(20):1553-1562. doi: 10.1111/1759-7714.15377. Epub 2024 May 29.
7
Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.外科医生更倾向于对小于 3cm 的 I 期非小细胞肺癌行亚肺叶切除术。
Thorac Cancer. 2020 Apr;11(4):907-917. doi: 10.1111/1759-7714.13336. Epub 2020 Feb 9.
8
Wedge resection, segmentectomy, and lobectomy: oncologic outcomes based on extent of surgical resection for ≤2 cm stage IA non-small cell lung cancer.楔形切除术、肺段切除术和肺叶切除术:基于手术切除范围的≤2 cm IA期非小细胞肺癌的肿瘤学结局
J Thorac Dis. 2024 Mar 29;16(3):1875-1884. doi: 10.21037/jtd-23-1693. Epub 2024 Mar 15.
9
Less is more in solid-dominant lung cancer? Sublobar resection versus lobectomy for solid-dominant stage IA non-small-cell lung cancer: A meta-analysis study.实性为主型肺癌中少即是多?亚肺叶切除术与肺叶切除术治疗实性为主型IA期非小细胞肺癌的Meta分析研究
Mol Clin Oncol. 2019 Nov;11(5):465-473. doi: 10.3892/mco.2019.1914. Epub 2019 Aug 22.
10
Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.非小细胞肺癌行肺叶切除术、节段切除术和楔形切除术的生存率。
Ann Thorac Surg. 2018 May;105(5):1483-1491. doi: 10.1016/j.athoracsur.2018.01.032. Epub 2018 Feb 17.

引用本文的文献

1
Segmentectomy Versus Wedge Resection for Stage IA Lung Adenocarcinoma-A Population-Based Study.肺叶切除术与楔形切除术治疗IA期肺腺癌的基于人群的研究
Cancers (Basel). 2025 Mar 10;17(6):936. doi: 10.3390/cancers17060936.
2
Survival after thermal ablation versus wedge resection for stage I non-small cell lung cancer < 1 cm and 1 to 2 cm: evidence from the US SEER database.热消融与楔形切除术治疗Ⅰ期非小细胞肺癌(肿瘤直径≤1cm 和 1-2cm)的生存比较:来自美国 SEER 数据库的证据。
Cancer Imaging. 2024 Jul 11;24(1):91. doi: 10.1186/s40644-024-00733-4.
3
Application of uniportal video-assisted thoracoscopic surgery for segmentectomy in early-stage non-small cell lung cancer: A narrative review.

本文引用的文献

1
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.小型周围型非小细胞肺癌的肺段切除术与肺叶切除术比较(JCOG0802/WJOG4607L):一项多中心、开放标签、3期、随机、对照、非劣效性试验
Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3.
2
Segmentectomy and Wedge Resection for Elderly Patients with Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.老年I期非小细胞肺癌患者的肺段切除术和楔形切除术:一项系统评价和荟萃分析
J Clin Med. 2022 Jan 6;11(2):294. doi: 10.3390/jcm11020294.
3
单孔电视辅助胸腔镜手术在早期非小细胞肺癌肺段切除术中的应用:一项叙述性综述。
Heliyon. 2024 May 3;10(9):e30735. doi: 10.1016/j.heliyon.2024.e30735. eCollection 2024 May 15.
4
Lobe-specific analysis of perioperative chemotherapy for non-small cell lung cancer patients.针对非小细胞肺癌患者的围手术期化疗的肺叶特异性分析。
Cancer Med. 2023 Aug;12(16):16896-16905. doi: 10.1002/cam4.6319. Epub 2023 Jul 5.
The Prognostic Significance of the Histological Types in Patients With Nonsmall Cell Lung Cancer ≤2 cm.
≤2厘米非小细胞肺癌患者组织学类型的预后意义
Front Surg. 2021 Oct 25;8:721567. doi: 10.3389/fsurg.2021.721567. eCollection 2021.
4
Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.80 岁以上早期非小细胞肺癌患者楔形切除术与肺叶切除术/肺段切除术的生存比较:JACS1303。
Ann Surg Oncol. 2021 Nov;28(12):7219-7227. doi: 10.1245/s10434-021-09835-w. Epub 2021 Apr 26.
5
Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer.临床ⅠA 期非小细胞肺癌患者行解剖性肺段切除术与楔形切除术的肿瘤控制效果比较。
J Thorac Cardiovasc Surg. 2021 Oct;162(4):1244-1252.e1. doi: 10.1016/j.jtcvs.2020.10.024. Epub 2020 Oct 22.
6
Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.临床ⅠA 期非小细胞肺癌磨玻璃密度成分的预后影响。
J Thorac Cardiovasc Surg. 2021 Apr;161(4):1469-1480. doi: 10.1016/j.jtcvs.2020.01.107. Epub 2020 Apr 6.
7
Postoperative Complications and Cancer Recurrence: Impact on Poor Prognosis of Lower Lobe Cancer.术后并发症与癌症复发:对下叶肺癌不良预后的影响。
Ann Thorac Surg. 2020 Jun;109(6):1750-1756. doi: 10.1016/j.athoracsur.2019.12.061. Epub 2020 Feb 10.
8
Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype.肺腺癌表现为影像学部分实性结节定义了一种特殊的临床亚型。
J Thorac Oncol. 2019 Apr;14(4):617-627. doi: 10.1016/j.jtho.2018.12.030. Epub 2019 Jan 17.
9
Meta-analysis of segmentectomy versus wedge resection in stage IA non-small-cell lung cancer.IA期非小细胞肺癌肺段切除术与楔形切除术的Meta分析。
Onco Targets Ther. 2018 Jun 7;11:3369-3375. doi: 10.2147/OTT.S161367. eCollection 2018.
10
Pulmonary function changes after different extent of pulmonary resection under video-assisted thoracic surgery.电视辅助胸腔镜手术下不同肺切除范围后的肺功能变化
J Thorac Dis. 2018 Apr;10(4):2331-2337. doi: 10.21037/jtd.2018.03.163.